Cargando…

Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry

BACKGROUND: Colon cancer (CC) is a disease of elderly patients (pts.) with a median age of 73 years (yrs.). Lack of data about the effects of adjuvant chemotherapy (ACT) is caused by underrepresentation of this clinically relevant cohort in interventional trials. We analyzed real‐world data from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nöpel‐Dünnebacke, Stefanie, Jütte, Hendrick, Denz, Robin, Feder, Inke Sabine, Kraeft, Anna‐Lena, Lugnier, Celine, Teschendorf, Christian, Collette, Daniela, Böhner, Hinrich, Engel, Lars, Mueller, Lothar, Hartmann, Frank, Kaiser, Ulrich, Bruch, Harald‐Robert, Hollerbach, Stephan, Arnold, Dirk, Timmesfeld, Nina, Tannapfel, Andrea, Reinacher‐Schick, Anke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041084/ https://www.ncbi.nlm.nih.gov/pubmed/35146948 http://dx.doi.org/10.1002/cam4.4540

Ejemplares similares

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
por: Ettrich, Thomas J., et al.
Publicado: (2018)

Aios in coronatijd
por: Maria Greijn, Claudia, et al.
Publicado: (2020)

Complete mesocolic excision for right colonic cancer: prospective multicentre study
por: Benz, Stefan R, et al.
Publicado: (2022)

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial
por: Stintzing, Sebastian, et al.
Publicado: (2018)

Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group
por: Reinacher-Schick, Anke, et al.
Publicado: (2012)

UICC Technical Report Series
por: Potten, C. S.
Publicado: (1976)

Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer—a study in AIO oncologists
por: Büttelmann, M., et al.
Publicado: (2023)

407P Cross-sectoral colorectal cancer care in Germany in the context of the COVID-19 pandemic and scarcity of resources
por: Lugnier, C., et al.
Publicado: (2022)

AIOS proceedings: A response
por: Rajendran, Babu
Publicado: (2009)

19. AIO-Herbstkongress 2022
Publicado: (2023)

Label-free, automated classification of microsatellite status in colorectal cancer by infrared imaging
por: Kallenbach-Thieltges, Angela, et al.
Publicado: (2020)

Visualizing the (Causal) Effect of a Continuous Variable on a Time-To-Event Outcome
por: Denz, Robin, et al.
Publicado: (2023)

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group
por: Modest, D. P., et al.
Publicado: (2016)

UICC-ARO Symposium at the UICC 2016 World Cancer Congress How Can We Mobilize Action to Realize UHC in Asia?
por: Akaza, Hideyuki, et al.
Publicado: (2017)

The Interactions of CPP–ACP with Saliva
por: Huq, Noorjahan Laila, et al.
Publicado: (2016)

Trends and Challenges in AIoT/IIoT/IoT Implementation
por: Hou, Kun Mean, et al.
Publicado: (2023)

Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials
por: Noepel-Duennebacke, Stefanie, et al.
Publicado: (2021)

1333P S1 Guideline for prioritisation in gastrointestinal cancer care: Scarcity of resources in the pandemic context
por: Reinacher-Schick, A., et al.
Publicado: (2022)

The effect of fibre size on the in vivo activity of UICC crocidolite.
por: Wagner, J. C., et al.
Publicado: (1984)

Factors involved in the cytotoxicity of UICC amosite towards macrophages.
por: Davies, R, et al.
Publicado: (1983)

Increased risk of critical CBF levels in SAH patients with actual CPP below calculated optimal CPP
por: Johnson, Ulf, et al.
Publicado: (2017)

Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional survey
por: Sommerlatte, Sabine, et al.
Publicado: (2023)

The complete guide for CPP examination preparation
por: DiSalvatore, Anthony V, et al.
Publicado: (2016)

The Complete Guide for CPP Examination Preparation
por: DiSalvatore, Anthony
Publicado: (2015)

The in vitro remineralizing effect of CPP-ACP and CPP-ACPF after 6 and 12 weeks on initial caries lesion
por: Thierens, Laurent A. M., et al.
Publicado: (2019)

AIOS Constitution Reforms - Change is the Secret Sauce for Success
por: Honavar, Santosh G
Publicado: (2021)

AIoT Used for COVID-19 Pandemic Prevention and Control
por: Chen, Shu-Wen, et al.
Publicado: (2021)

Lung Cancer. UICC Technical Report Series, Vol. 25
por: Kinlen, L. J.
Publicado: (1977)

Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
por: Juntermanns, Benjamin, et al.
Publicado: (2012)

Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma
por: Juntermanns, Benjamin, et al.
Publicado: (2018)

The burden of Chronic Pelvic Pain (CPP): Costs and quality of life of women and men with CPP treated in outpatient referral centers
por: Hutton, David, et al.
Publicado: (2023)

Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients
por: Overheu, Oliver, et al.
Publicado: (2023)

Antinociceptive interaction of (±)-CPP and propentofylline in monoarthritic rats
por: Morales, Francisco, et al.
Publicado: (2012)

Building Cell Selectivity into CPP-Mediated Strategies
por: Martín, Irene, et al.
Publicado: (2010)

Outcome of girls with central precocious puberty (CPP)
por: Shah, Ruchi, et al.
Publicado: (2015)

CPP or Not, That Is the Question: Physicians’ Work With Activating CPPs
por: Næss, Siri Christine K.
Publicado: (2021)

An Oxidoreductase AioE is Responsible for Bacterial Arsenite Oxidation and Resistance
por: Wang, Qian, et al.
Publicado: (2017)

Evaluation of the 7th UICC TNM Staging System of Gastric Cancer
por: Kwon, Sung Joon
Publicado: (2011)

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
por: Teufel, Andreas, et al.
Publicado: (2015)

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
por: Kurreck, A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_esr75dj9jafv9ta8ll1lkq56gh